and N-activated aziridines, 5 the number of reports on the ring-opening of N-activated aziridine 2-carboxylate esters is fewer. In all such reactions the nucleophile can attack at either the αor β-position of the aziridine ring to give regioisomeric products ( Figure 1) .
In a recent review, 3a De Kimpe and Ha stated that "the regioselectivity in the ringopening reactions of 2-substituted activated aziridines has been shown to be quite straightforward, mostly involving the nucleophilic attack at the less hindered carbon atom, with some exceptional cases comprising the nucleophilic attack at the benzylic position". An examination of the regioselectivity of these reactions shows that the outcome is not always that predictable, 6 particularly when the nucleophile is a primary amine, and the 2-substituent is also electron-withdrawing (e.g. an ester group). For example, Rich found that reaction of N-tosyl aziridine 2-carboxylic acid with methylamine gave a 1:1 ratio of products resulting from αand β-attack. 7 However, when the steric hindrance at the 2-position was increased, by using the 2tert-butyl ester derivative, the α:β ratio was 1:6.3. The van Boom group found a 3.5:1 ratio, in favour of attack at the less hindered β-position, for the reaction of benzylamine with N-ortho-nitrobenzenesulfonyl (o-Ns) azridine 2-t-butyl ester, which increased to a 15-17:1 ratio when the primary amine was an α-amino acid ester. 8 When the steric hindrance was increased significantly, by linking the ester group at the aziridine 2-position to a solid support, Olsen found that this led to exclusive attack at the less hindered β-position, with no evidence for any α-attack. 9 The Franzyk group reported a 9:1 ratio, in favour of β-attack, when the ester group of an α-amino ester was linked to a solid support, and it was reacted with N-pNs aziridine methyl 2-
carboxylate. 5h
As part of an ongoing programme of research towards the synthesis of peptides incorporating unusual amino acid residues, we are interested in the synthesis of βmonoalkyl substituted 1,2-diaminopropanoic acids (DAPs). In particular, the use of orthogonally protected DAPs would allow their incorporation into peptide structures and then their subsequent derivatisation. We previously reported the synthesis, and subsequent use, of such orthogonally protected DAPs for the preparation of orthogonally protected azalanthionines (lanazanines), which are nitrogen-linked analogues of the more common amino acid lanthionine ( Figure 2 ). 10 The required DAPs were prepared by the ring-opening of 3-unsubstituted N-activated aziridine 2-carboxylate esters with benzylamines, or by the Mitsunobu reaction of serine derivatives. 11 During the aziridine ring-opening reactions it was found that there were issues with the regioselectivity of the reactions, depending on the choice of N-protecting group and ester group at the aziridine 2-position. Since the initial results showed that the regiochemical outcome was not straightforward, an extended study was undertaken to determine whether the regioselectivity was in any way predictable.
The required N-activated aziridine 2-carboxylates were prepared as shown in Scheme 1. 10, 12 In each case the protecting groups chosen were those that have been used previously in solid-phase peptide syntheses, particularly in the preparation of lanthionine containing peptides and their analogues. 12 Thus the N-protecting groups used were Ts, para-nitrobenzenesulfonyl (p-Ns) and para-nitrobenzyloxycarbony (p-Nz), while the methyl and allyl esters were chosen for the aziridine 2-position. Preparation of a DAP with the β-amino group also being protected was achieved by ring-opening of aziridine 2a with para-methoxybenzylamine (PMB-NH 2 ) following the method of Kim. 13 This involved heating the reaction to 80 o C in acetonitrile for 24 hours with two molar equivalents of PMB-NH 2 , which gave the two regioisomeric products from nucleophilic attack at either the αor β-positions of the aziridine. The PMB group was chosen because it can be easily removed in solid-phase synthesis. The yield of the product (Table 1 ) from attack at the less hindered β-position was 32%, while attack at the α-position gave a 41% yield (entry 1).
Conducting the reaction at room temperature for 24 hours gave a reversal in the observed selectivity, with the β-attack giving a yield of 70% and α-attack of 23%
(entry 2). The selectivity observed at higher temperatures was not unexpected, but the 23% yield of the compound isolated from attack at the hindered α-position, at room temperature, was somewhat of a surprise. Since the conditions required to remove the tosyl group are very harsh for solid-phase peptide synthesis the alternative N-activating, peptide-friendly, p-Ns and p-Nz groups were chosen, for comparison with the N-tosyl aziridine 2a. (Note: the N-Fmoc protected aziridine was not chosen because it was felt that the secondary amino DAP product might lead to a loss of the Fmoc group). As can be seen, from Table 1, Therefore, in order to extend this study, it was thought that changing the ester methyl group, again to the more peptide-friendly allyl ester group, would be advantageous.
However, this small change led to some surprising results (Table 1) . To keep the results comparable PMB-NH 2 was again used as the nucleophile. In this case aziridines 2b and 3b did not give any reaction products (entries 5 and 6), at either room temperature or at 80 o C in acetonitrile, while the p-Nz aziridine 4b again gave only β-attack, giving DAP 6d, in an isolated yield of 66% (entry 7). The N-alloc protected aziridine allyl ester 5b also did not give any reaction at either room temperature or 80 o C (entry 8), which was surprising when compared to Harada's study with a Cbz-protected aziridine (vide supra).
It was clear that the observed regioselectivity of ring-opening was not predictable, with small changes in the choice of activating groups leading to quite different outcomes. Since the primary amine employed in these studies was kept constant we next examined the aziridine partner, in order to try to understand the observed regioselectivity. Perhaps an analysis of the 1 H NMR chemicals shifts of the αand β-protons of the aziridine rings, along with their corresponding carbon chemical shifts in 13 C NMR spectra, would help the understanding of the observed results (Table 2) .
However, it can be seen that there is very little difference between the analogous 1 H and 13 C NMR spectral chemical shifts of the aziridines 2-5. It is therefore difficult to make a definitive prediction of the regioselectivity for a particular ring-opening reaction of 3-unsubstituted N-activated aziridine 2-carboxylate esters with a primary amine.
In conclusion, we have shown that the ring-opening of N-activated aziridine 2carboxylate esters with p-methoxybenzylamine is far from predictable. We are currently undertaking in-depth computational studies on these reactions, including an examination of possible transition states and their energies, in order to try to understand the experimental results observed. The chemistry is also being extended to the synthesis of the corresponding orthogonally protected β-methyl DAPs, by ringopening of 3-methyl N-activated aziridine 2-carboxylate esters, en route to the aza analogues of the β-methyllanthionines found in the ring structures of many important lantibiotics. 15 The results of all of these studies will be reported in due course.
A typical procedure is exemplified by the synthesis of 6a and 7a. To a solution of the relevant aziridine (2 mmol) in CH 3 CN (5 ml) was added p-methoxybenzylamine (0.52 ml, 4 mmol) and the solution was stirred for 24 h at room temperature. The solvent was removed in vacuo, and then the residue was re-dissolved in EtOAc (20 ml 2, 158.7, 143.7, 136.6, 131.3, 129.6, 129.3, 127.2, 113.8, 60.4, 55.3, 52.6, 52.3, 50.0, 21.5 ; IR (thin film, NaCl, cm -1 ) 3347, 3089, 2981, 1744, 1188, 1150 9, 158.9, 143.5, 136.6, 131.0, 129.7, 129.4, 127.0, 113.9, 59.0, 55.3, 52.3, 51.2, 44.2, 21.5 ; IR (thin film, NaCl, cm -1 ) 3359, 3082, 2991, 1743, 1224, 1124 . Scheme 1: Synthesis of N-activated aziridine 2-carboxylate esters 10, 12 
